Kin Iong Chan

Molecular landscape and subtype-specific therapeutic response of nasopharyngeal carcinoma revealed by integrative pharmacogenomics

Ren‐Bo Ding, Ping Chen, Barani Kumar Rajendran et al. · Nature Communications · 2021 · 91 citations · Full text

Integrative Pharmacogenomics, Subtype-specific Therapeutic Response, Pathology +16

Diagnostic utility of glypican-3 for hepatocellular carcinoma on liver needle biopsy

Feng Hua Wang, Yuk Ching Yip, Meng Zhang et al. · Journal of Clinical Pathology · 2010 · 41 citations · Full text

Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinoma

Yabing Cao, Kin Iong Chan, Gungli Xiao et al. · BMC Cancer · 2019 · 18 citations · Full text

A novel combination treatment of antiADAM17 antibody and erlotinib to overcome acquired drug resistance in non-small cell lung cancer through the FOXO3a/FOXM1 axis

Junnan Li, Pengchen Chen, Qiushuang Wu et al. · Cellular and Molecular Life Sciences · 2022 · 15 citations · Full text

Novel Combination Treatment, Health Sciences, Medicine +11

Novel Therapeutic Anti-ADAM17 Antibody A9(B8) Enhances EGFR-TKI–Mediated Anticancer Activity in NSCLC

Zheng Yang, Kin Iong Chan, Hang Fai Kwok et al. · Translational Oncology · 2019 · 12 citations · Full text

Egfr-tki–mediated Anticancer Activity, Novel Therapy, Nsclc Cell Lines +13